It is required for both DNA and RNA synthesis as well as for energy production in the form of ATP
Combining glucagon-like peptide 1 receptor agonists and sodiumglucose cotransporter 2 inhibitors to target multiple organ defects in type 2 diabetes
Wu, J., Kong, M., Lou, Y., Li, L., Yang, C., Xu, H., et al
However, this should be approached cautiously and only after extended plateaus (6+ weeks of stable weight despite consistent protocol adherence)
Timing your first dose should account for several practical factors: Dietary planning : Consider starting when you can maintain a regular eating pattern and have access to light, easily digestible meals, as gastrointestinal side effects are most common initially Monitoring capability : Choose a time when you can observe your body's response and have access to medical advice if needed Social calendar : Avoid starting immediately before important events, travel, or periods of high stress Support availability : Begin when family members or carers are available to assist if you experience side effects Dose escalation protocols are standard with GLP-1 therapy to minimise adverse effects